PRAX
Praxis Precision Medicines, Inc.
Latest close $319.23 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment | Earliest Schedule 13G amendment found | 2.2K | 12.00% | $322.19 | $338.07 | $319.23 |
| T. Rowe Price Associates CIK0000080255 | Sep 30, 2025 observed Nov 14, 2025 filed · 45d Schedule 13G amendment | Earliest Schedule 13G amendment found | 1.0M | 12.00% | $53.00 | $186.42 | $319.23 |
| Capital Research Global Investors CIK0001422848 | Mar 31, 2025 observed May 13, 2025 filed · 43d Schedule 13G amendment | Earliest Schedule 13G amendment found | 20.2M | 12.00% | $319.23 |